GLOBAL RESEARCH SYNDICATE
No Result
View All Result
  • Login
  • Latest News
  • Consumer Research
  • Survey Research
  • Marketing Research
  • Industry Research
  • Data Collection
  • More
    • Data Analysis
    • Market Insights
  • Latest News
  • Consumer Research
  • Survey Research
  • Marketing Research
  • Industry Research
  • Data Collection
  • More
    • Data Analysis
    • Market Insights
No Result
View All Result
globalresearchsyndicate
No Result
View All Result
Home Data Analysis

Diabetes in OA: Pain Is Worse

globalresearchsyndicate by globalresearchsyndicate
March 3, 2020
in Data Analysis
0
Diabetes in OA: Pain Is Worse
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

Among patients with knee osteoarthritis (OA), pain was greater for those with coexisting diabetes mellitus (DM), and this association was independent of obesity and radiographic severity, European researchers found.

In an analysis that adjusted for age, sex, body mass index (BMI), and Kellgren-Lawrence grade of radiographic severity, pain was more severe on the activity-based Knee injury and Osteoarthritis Outcome Score (KOOS) for patients with DM compared with those without DM (β = -4.72, 95% CI -7.22 to -2.23, P<0.001), according to Annett Eitner, PhD, of Friedrich Schiller University in Jena, Germany, and colleagues.

In addition, pain was worse for patients with DM on an 11-point numerical rating scale of non-activity-related pain (β = 0.42, 95% CI 0.04 to 0.80, P=0.31), the researchers reported online in Arthritis Care & Research.

Pain intensity has been reported to be greater in OA patients who have DM, possibly because of increased systemic and local inflammation, microvascular changes, and pain sensitization alterations. Moreover, hyperglycemia may have adverse influences including mitochondrial dysfunction, hypoxia, and release of reactive oxygen specials in peripheral tissues, potentially contributing to abnormal nociception and peripheral neuropathy.

But identifying the precise mechanisms of OA pain can be difficult, as pain severity doesn’t always align with the degree of radiographic change and BMI can be a confounder because of mechanical stress on weight-bearing joints as well as upregulation of proinflammatory cytokines from adipose tissue, the researchers explained.

“Given that previous studies into the relationship between DM and OA pain were of moderate sample size only and did not adjust for radiographic OA severity, the current study used a large observational cohort to test the hypothesis that OA pain sensation in individuals with DM is stronger than in non-DM controls, independently of BMI and radiographic disease status,” Eitner and colleagues wrote.

For the research, they analyzed data from 2,481 patients enrolled in the Osteoarthritis Initiative, a longitudinal cohort study of individuals with symptomatic OA ages 45 to 79. Of these, 202 (8.14%) reported having been diagnosed with DM.

Compared with the patients who did not have diabetes, those with DM were older (65 vs 62 years, P=0.032), had higher BMI (31.6 vs 28.6 kg/m2, P<0.001), and had higher comorbidity scores (1 vs 0, P<0.001). Comorbidities in the DM group included heart failure, impaired kidney function, and cancer.

Kellgren-Lawrence radiographic severity categories were grade 1 in 27%, grade 2 in 42.2%, grade 3 in 23.1%, and grade 4 in 7.7%.

“Importantly,” pain was worse in diabetic patients with the higher Kellgren-Lawrence grades, the authors noted. Patients with DM and the most severe radiographic grade (4), had a difference of 11.1 points compared with non-DM patients (P=0.014) and a difference of 2.5 points on the numerical rating scale of pain (P=0.013).

On other outcomes, patients with severe OA and DM had a 49-point difference on the Physical Activity Score for the Elderly compared with nondiabetic patients (P=0.030) and a difference of 7.1 points on the Short Form-12 health assessment physical summary score (P=0.30).

On the multivariate linear regression analysis that adjusted for age, sex, BMI, and Kellgren-Lawrence grade, factors other than pain severity that were significantly different between patients with and without DM were as follows:

  • Short Form-12 physical summary score, β = -3.49 (95% CI -4.73 to -2.25, P<0.001)
  • Short Form 12 mental summary score, β = -1.42 (95% CI -2.57 to -0.26, P=0.016)
  • Center for Epidemiological Studies Depression Scale, β = 1.08 (95% CI 0.08 to 2.08, P=0.035)

After additional adjustment for pain medication use, comorbidities, and number of painful joints, these factors remained statistically significant:

  • KOOS pain, β = -3.32 (95% CI -5.62 to -1.02, P=0.005)
  • Short Form-12 physical summary score, β = -2.63 (95% CI -3.81 to -1.45, P<0.001)
  • Short Form-12 mental summary score, β = -1.19 (95% CI -2.36 to -0.03, P=0.045)

This analysis confirmed that not only do patients with OA and DM experience worse pain than those without DM, but they also have worse physical and mental health status, the researchers observed.

“The inclusion of additional potential confounders such as other diagnosed comorbidities, painful joints, and pain medication into the analysis confirms the presence of DM and worse KOOS pain scores of knee joints in OA-affected individuals,” the team wrote.

“In summary, greater inflammation, alterations in nociceptive neurons, diabetic neuropathy, and psychosocial factors may cause the presence of DM to result in more knee pain, independent of elevated BMI and radiographic OA status,” Eitner and co-authors concluded.

Limitations of the analysis, the team said, included the cross-sectional design and lack of details regarding DM history.

Last Updated March 03, 2020

Disclosures

The authors received no funding for this work.

The Osteoarthritis Initiative is in a public-private partnership between the National Institutes of Health and Merck, Novartis, GlaxoSmithKline, and Pfizer.

Eitner reported no disclosures. One co-author reported being a co-owner of Chondrometrics GmbH and working there part-time, as well as having a financial relationship with Galapagos; another co-owner reported being CEO of Chondrometrics GmbH and having financial relationships with Merck, Novartis, Bioclinica/Synarc, Samumed, AbbVie, Tissuegene, Servier, Galapagos, Roche, Medtronic, Pfizer, Eli Lilly, Stryker, Ampio, BICL, OrthoTrophix, Medivir, Servier, and Galapagos.

Related Posts

How Machine Learning has impacted Consumer Behaviour and Analysis
Consumer Research

How Machine Learning has impacted Consumer Behaviour and Analysis

January 4, 2024
Market Research The Ultimate Weapon for Business Success
Consumer Research

Market Research: The Ultimate Weapon for Business Success

June 22, 2023
Unveiling the Hidden Power of Market Research A Game Changer
Consumer Research

Unveiling the Hidden Power of Market Research: A Game Changer

June 2, 2023
7 Secrets of Market Research Gurus That Will Blow Your Mind
Consumer Research

7 Secrets of Market Research Gurus That Will Blow Your Mind

May 8, 2023
The Shocking Truth About Market Research Revealed!
Consumer Research

The Shocking Truth About Market Research: Revealed!

April 25, 2023
market research, primary research, secondary research, market research trends, market research news,
Consumer Research

Quantitative vs. Qualitative Research. How to choose the Right Research Method for Your Business Needs

March 14, 2023
Next Post
Blockchain may be the answer to marketers’ trust gap

Blockchain may be the answer to marketers' trust gap

Categories

  • Consumer Research
  • Data Analysis
  • Data Collection
  • Industry Research
  • Latest News
  • Market Insights
  • Marketing Research
  • Survey Research
  • Uncategorized

Recent Posts

  • Ipsos Revolutionizes the Global Market Research Landscape
  • How Machine Learning has impacted Consumer Behaviour and Analysis
  • Market Research: The Ultimate Weapon for Business Success
  • Privacy Policy
  • Terms of Use
  • Antispam
  • DMCA

Copyright © 2024 Globalresearchsyndicate.com

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT
No Result
View All Result
  • Latest News
  • Consumer Research
  • Survey Research
  • Marketing Research
  • Industry Research
  • Data Collection
  • More
    • Data Analysis
    • Market Insights

Copyright © 2024 Globalresearchsyndicate.com